Equities research analysts at StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research note issued to investors on Monday. The firm set a “sell” rating on the medical research company’s stock.
OpGen Stock Performance
Shares of OpGen stock opened at $2.10 on Monday. OpGen has a one year low of $0.53 and a one year high of $9.90. The firm has a fifty day moving average of $1.15 and a two-hundred day moving average of $1.42.
OpGen Company Profile
Featured Stories
- Five stocks we like better than OpGen
- Using the MarketBeat Dividend Tax Calculator
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Profitably Trade Stocks at 52-Week Highs
- 3 Must-Own Stocks to Build Wealth This Decade
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.